Literature DB >> 3230138

Nucleic acid hybridization for detection of cell culture-amplified adenovirus.

C Huang1, R Deibel.   

Abstract

A number of recombinant plasmids containing genomic segments of adenovirus were constructed. Seven cloned probes, as well as total adenovirus type 2 (Ad2) and Ad16 genomic DNA, were tested by a nucleic acid hybridization technique for sensitivity and specificity in detecting adenoviruses in infected cells. Adenovirus DNA was spotted onto a nitrocellulose filter and hybridized with 32P-labeled DNA probes. The probes, total Ad2 genomic DNA, and plasmid pAd2-H (containing the hexon gene from Ad2 DNA) all detected 10 reference serotypes of five genomic subgroups (A through E) with similar sensitivities. However, plasmid pAd2-H required less preparation time than did total Ad2 DNA. Probes pAd2-F (containing the fiber gene from Ad2) and pAd16-BD (containing the BamHI D fragment from Ad16) hybridized only with reference serotypes from the homologous subgroups (C and B, respectively). Of 101 patient isolates amplified in cells, pAd2-H detected 100% of all isolates from both the homologous and the heterologous subgroups. The detection rates for pAd2-F were 100% (subgroup C) and 3.6% (subgroups A, B, and D), and those for pAd16-BD were 100% (subgroup B) and 9.4% (subgroups A, C, and D). A commercial biotinylated product (Pathogene II) was also included in this study for comparison.

Entities:  

Mesh:

Year:  1988        PMID: 3230138      PMCID: PMC266965          DOI: 10.1128/jcm.26.12.2652-2656.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  DNA hybridization for diagnosis of enteric adenovirus infection from directly spotted human fecal specimens.

Authors:  G Hammond; C Hannan; T Yeh; K Fischer; G Mauthe; S E Straus
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Thirty-one human adenovirus serotypes (Ad1-Ad31) form five groups (A-E) based upon DNA genome homologies.

Authors:  M Green; J K Mackey; W S Wold; P Rigden
Journal:  Virology       Date:  1979-03       Impact factor: 3.616

Review 4.  The structural and functional diversity of Adenovirus capsid components.

Authors:  E Norrby
Journal:  J Gen Virol       Date:  1969-09       Impact factor: 3.891

5.  The relationship between the soluble antigens and the virion of adenovirus type 3. V. Identification of antigen specificities available at the surface of virions.

Authors:  E Norrby; H Marusyk; M L Hammarskjöld
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

6.  Nucleotide sequence at the junction between the coding region of the adenovirus 2 hexon messenger RNA and its leader sequence.

Authors:  G Akusjärvi; U Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  Nucleotide sequence of the EcoRI-F fragment of adenovirus 2 genome.

Authors:  F Galibert; J Hérissé; G Courtois
Journal:  Gene       Date:  1979-05       Impact factor: 3.688

8.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

9.  The purification of adenovirus neutralizing antibody: adenovirus type 5 hexon immunoadsorbent.

Authors:  A T Haase; H G Pereira
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

10.  Relationship between deoxyribonucleic acid-like ribonucleic acid synthesis and inhibition of host protein synthesis in type 5 adenovirus-infected KB cells.

Authors:  L J Bello; H S Ginsberg
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103

View more
  1 in total

1.  Detection of enteric adenoviruses with synthetic oligonucleotide probes.

Authors:  T H Scott-Taylor; G Ahluwalia; M Dawood; G W Hammond
Journal:  J Med Virol       Date:  1993-12       Impact factor: 2.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.